Back to top
more

InMode (INMD)

(Real Time Quote from BATS)

$13.92 USD

13.92
456,452

+0.18 (1.31%)

Updated Aug 4, 2025 01:14 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 30% (173 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Investors Heavily Search InMode Ltd. (INMD): Here is What You Need to Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.

Zacks Equity Research

NanoString Technologies (NSTG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

NanoString (NSTG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

InMode (INMD) Registers a Bigger Fall Than the Market: Important Facts to Note

by Zacks Equity Research

InMode (INMD) closed at $19.13 in the latest trading session, marking a -0.62% move from the prior day.

Zacks Equity Research

Analysts Estimate InMode (INMD) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

InMode (INMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Here is What to Know Beyond Why InMode Ltd. (INMD) is a Trending Stock

by Zacks Equity Research

InMode (INMD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks Equity Research

InMode (INMD) to Post Q3 Earnings: What's in the Cards?

by Zacks Equity Research

InMode (INMD) is likely to register growth in Q3, backed by strong consumable and service revenues and ongoing global expansion.

Zacks Equity Research

InMode (INMD) Stock Moves -0.81%: What You Should Know

by Zacks Equity Research

In the most recent trading session, InMode (INMD) closed at $19.70, indicating a -0.81% shift from the previous trading day.

Zacks Equity Research

InMode (INMD) Registers a Bigger Fall Than the Market: Important Facts to Note

by Zacks Equity Research

InMode (INMD) reachead $21.23 at the closing of the latest trading day, reflecting a -0.42% change compared to its last close.

Zacks Equity Research

InMode (INMD) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

InMode (INMD) closed the most recent trading day at $30.13, moving -1.08% from the previous trading session.

Zacks Equity Research

Is Trending Stock InMode Ltd. (INMD) a Buy Now?

by Zacks Equity Research

InMode (INMD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks Equity Research

InMode (INMD) Stock Moves -0.52%: What You Should Know

by Zacks Equity Research

InMode (INMD) closed at $32.24 in the latest trading session, marking a -0.52% move from the prior day.

Zacks Equity Research

InMode (INMD) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

InMode (INMD) closed at $33.07 in the latest trading session, marking a -1.96% move from the prior day.

Zacks Equity Research

Is Most-Watched Stock InMode Ltd. (INMD) Worth Betting on Now?

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to InMode (INMD). This makes it worthwhile to examine what the stock has in store.

Zacks Equity Research

InMode (INMD) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

InMode (INMD) closed at $34.91 in the latest trading session, marking a +1.28% move from the prior day.

Zacks Equity Research

InMode (INMD) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

InMode (INMD) closed the most recent trading day at $37.91, moving -0.73% from the previous trading session.

Zacks Equity Research

InMode Ltd. (INMD) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how HealthEquity (HQY) and InMode (INMD) have performed compared to their sector so far this year.

Zacks Equity Research

InMode (INMD) Outpaces Stock Market Gains: What You Should Know

by Zacks Equity Research

InMode (INMD) closed at $39.49 in the latest trading session, marking a +1.02% move from the prior day.

Zacks Equity Research

Here's Why Investors Should Hold Humana (HUM) in Portfolio

by Zacks Equity Research

Humana (HUM) remains well-poised for growth on the back of an expanding Medicare Advantage membership, upgraded health plan offering suite and solid cash reserves.

Zacks Equity Research

Cigna (CI) Eases Care Delivery With Prior Authorization Removal

by Zacks Equity Research

Cigna's (CI) branch, Cigna Healthcare, lifts the prior authorization requirement on 600-plus medical services, thereby easing administrative burdens and making way for simplified care delivery.

Zacks Equity Research

InMode Ltd. (INMD) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching InMode (INMD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Zacks Equity Research

Has HealthEquity (HQY) Outpaced Other Medical Stocks This Year?

by Zacks Equity Research

Here is how HealthEquity (HQY) and InMode (INMD) have performed compared to their sector so far this year.

Zacks Equity Research

InMode (INMD) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

InMode (INMD) delivered earnings and revenue surprises of 2.86% and 0.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Are Medical Stocks Lagging InMode (INMD) This Year?

by Zacks Equity Research

Here is how InMode (INMD) and Akebia Therapeutics (AKBA) have performed compared to their sector so far this year.

Zacks Equity Research

InMode (INMD) to Post Q2 Earnings: What's in the Cards?

by Zacks Equity Research

InMode (INMD) is expected to report strong Q2 consumable and service revenues, banking on strong performances of seven patented technologies across 10 product families.